Search
Search Results
##search.searchResults.foundPlural##
-
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4401PDF: 3614HTML: 226 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3769PDF: 1492HTML: 190 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4449PDF: 1737HTML: 1064 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2616PDF: 883HTML: 2127 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3613PDF: 2546HTML: 1510 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2198PDF: 1737HTML: 385 -
-
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4107PDF: 1168HTML: 2002Fig.1: 222Fig. 2: 114Table 1: 208Table2: 226Table 3: 206 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3745PDF: 1638HTML: 83 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4818PDF: 1577HTML: 2254Untitled: 223Untitled: 244Untitled: 250Untitled: 226Untitled: 231 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1432PDF: 836HTML: 3125 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3285PDF: 1477HTML: 5958Fig1-Ag-Pil: 238Ag-Pil Fig.2: 240 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1326PDF: 478HTML: 18617Figure 1: 174Figure 2: 154Figure 3: 171Figure 4: 210Figure 5: 182 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1378HTML: 333PDF: 964Suppl. Files: 473 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1316PDF: 508HTML: 208 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2656PDF: 1638HTML: 2376Table1: 198 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2072PDF: 825HTML: 1055 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3278PDF: 1034HTML: 2055 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1912PDF: 792HTML: 534 -
-
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3109PDF: 888HTML: 7177Kost Fig1: 197Kost Fig 2: 189Kost Fig3: 188Kost Fig 4: 200Kost Fig5: 197Kost fig 6: 182 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2333PDF: 1345HTML: 17103Bassan Fig.1: 152Bassan Fig.2: 164Bassan Fig.4: 144Fig.3: 209 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1604PDF: 1052HTML: 262 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1800PDF: 1008HTML: 1795Tables: 183 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1153PDF: 507HTML: 249 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1331PDF: 608HTML: 3189 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4207PDF: 1962HTML: 5341Table 1: 214 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3246PDF: 794HTML: 2975Figure 1a and 1b: 156Figure 2: 165Figure 3: 184Figure 4: 168Figure 5: 169Tables 1-5: 157 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1584PDF: 780HTML: 2163Untitled: 230Untitled: 202Untitled: 198Untitled: 210Untitled: 203 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4397PDF: 1537HTML: 1564Untitled: 242 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1617PDF: 636HTML: 356 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
1819PDF: 699HTML: 2422Untitled: 163Figure 1 a: 168Figure 1 b: 178Fig 1 c: 161Figure 1 d: 207 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1691PDF: 413HTML: 223







